Skip to contentX
Xenetic Biosciences, Inc.
X
XBIOXenetic Biosciences, Inc. Q2 2016 · 10-Q
Revenue—
Net Income-$47.77M-$47.77MN/M vs Q2 2015 EPS Diluted-$6.12-$6.12N/M vs Q2 2015 Operating Income-$43,262,890N/M Operating Cash Flowderived-$1,359,426N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xenetic Biosciences, Inc. · CIK 1534525 · Engraved from SEC EDGAR
Free Cash Flowderived-$1,359,426N/M ended Jun 30, 2016 · filed Aug 15, 2016 · 46 d after period end